Peptide based vaccine design: Synthesis and immunological characterization of branched polypeptide conjugates comprising the 276-284 immunodominant epitope of HSV-1 glycoprotein D

Journal of Peptide Science

Volumn 8, Issue 3, 2002, Pages 107-117

  Mezo, Gábor ^a   Dalmadi, Balázs ^b   Mucsi, Ilona ^c   Bosze, Szilvia ^a   Rajnavölgyi, Éva ^b   Hudecz, Ferenc ^a  

^a EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^b EÖTVÖS LORÁND UNIVERSITY   (Hungary)

^c UNIVERSITY OF SZEGED   (Hungary)

Author keywords

Antibody recognition; Epitope conjugates; HSV 1 epitope peptide; Protection against HSV 1 infection; Synthetic antigens

Indexed keywords

ASPARTIC ACID; EPITOPE; FREUND ADJUVANT; GLUTAMIC ACID; GLYCOPROTEIN D; POLYPEPTIDE; VACCINE; VIRUS GLYCOPROTEIN;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; CARBOXY TERMINAL SEQUENCE; CONJUGATE; CONTROLLED STUDY; COVALENT BOND; DRUG DESIGN; HERPES SIMPLEX VIRUS 1; IMMUNE RESPONSE; IMMUNOGENICITY; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTECTION;

AMINO ACIDS; ANIMALS; BINDING SITES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; EPITOPES; HERPESVIRUS 1, HUMAN; MASS SPECTROMETRY; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, INBRED CBA; PEPTIDES; TIME FACTORS; VACCINES, SUBUNIT; VIRAL ENVELOPE PROTEINS;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 0036192759     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.373     Document Type: Article

References (21)

1. Alteration of immunogenicity and antibody recognition of B-cell epitopes by synthetic branched polypeptide carriers with a poly[L-lysine] backbone
2. Synthesis and in vitro T cell immunogenicity of conjugates with dual specificities: Attachment of epitope peptides of 16 kDa and 38 kDa proteins from M.tuberculosis to branched polypeptide
3. Synthesis and immunological studies of α-conotoxin chimera containing an immunodominant epitope from the 268-284 region of HSV-1 gD protein
4. Synthesis and antibody recognition of mucin 1 - α-conotoxin chimera
5. Design of peptide and polypeptide vaccines
6. Molecular design versus empirical discovery in peptide-based vaccines. Coming to terms with fuzzy recognition sites and ill-defined structure-function relationship in immunology
7. An inquiry into the mechanisms of herpes simplex virus latency
8. Membrane fusion induced by herpes simplex virus
9. Glycoprotein D protects mice against lethal challenge with herpes simplex virus type 1 and 2
10. Herpes simplex virus
11. Herpes simplex virus glycoprotein D bound to the human receptor HveA
12. T cell epitopes of glycoprotein D of herpes simplex virus type 1
13. Synthesis and conjugation with carriers of herpes simplex virus glycoprotein-D peptides of predicted antigenicity
14. Epitope mapping of the 273-284 region of HSV-1 glycoprotein D by synthetic branched polypeptide-carrier conjugates
15. B-cell epitopes in herpes simplex virus (HSV-1) glycoprotein D (gD)
16. The influence of the branched polypeptide carrier on the immunogenicity of predicted epitopes of HSV-1 glycoprotein D
17. The use of branched polypeptide carrier based conjugates for the design of synthetic vaccine against HSV infection
18. Synthesis of HSV-1 epitope peptides with an acid sensitive Asp-Pro bond
19. Color test for detection of free terminal amino groups in the solid-phase synthesis of peptides
20. Noninvasive continuous monitoring of solid-phase peptide synthesis by an acid-base indicator
21. Synthesis, conformation, biodistribution and hormone related in vitro anti-tumor effect of a GnRH antagonist-branched polypeptide conjugate